全文获取类型
收费全文 | 2142篇 |
免费 | 157篇 |
国内免费 | 19篇 |
专业分类
耳鼻咽喉 | 3篇 |
儿科学 | 51篇 |
妇产科学 | 20篇 |
基础医学 | 297篇 |
口腔科学 | 7篇 |
临床医学 | 185篇 |
内科学 | 736篇 |
皮肤病学 | 13篇 |
神经病学 | 266篇 |
特种医学 | 75篇 |
外科学 | 190篇 |
综合类 | 12篇 |
预防医学 | 192篇 |
眼科学 | 3篇 |
药学 | 118篇 |
中国医学 | 2篇 |
肿瘤学 | 148篇 |
出版年
2023年 | 20篇 |
2022年 | 17篇 |
2021年 | 59篇 |
2020年 | 45篇 |
2019年 | 61篇 |
2018年 | 65篇 |
2017年 | 44篇 |
2016年 | 63篇 |
2015年 | 67篇 |
2014年 | 91篇 |
2013年 | 104篇 |
2012年 | 204篇 |
2011年 | 191篇 |
2010年 | 101篇 |
2009年 | 83篇 |
2008年 | 140篇 |
2007年 | 144篇 |
2006年 | 119篇 |
2005年 | 100篇 |
2004年 | 94篇 |
2003年 | 84篇 |
2002年 | 64篇 |
2001年 | 55篇 |
2000年 | 41篇 |
1999年 | 50篇 |
1998年 | 12篇 |
1996年 | 5篇 |
1995年 | 12篇 |
1994年 | 5篇 |
1993年 | 5篇 |
1992年 | 19篇 |
1991年 | 16篇 |
1990年 | 16篇 |
1989年 | 6篇 |
1988年 | 15篇 |
1987年 | 9篇 |
1986年 | 6篇 |
1985年 | 11篇 |
1984年 | 12篇 |
1983年 | 6篇 |
1982年 | 5篇 |
1979年 | 4篇 |
1978年 | 3篇 |
1977年 | 3篇 |
1973年 | 3篇 |
1970年 | 3篇 |
1969年 | 6篇 |
1968年 | 7篇 |
1967年 | 4篇 |
1966年 | 4篇 |
排序方式: 共有2318条查询结果,搜索用时 37 毫秒
1.
Sanne C. F. A. Huijberts Robin M. J. M. van Geel Emilie M. J. van Brummelen Frans L. Opdam Serena Marchetti Neeltje Steeghs Saskia Pulleman Bas Thijssen Hilde Rosing Kim Monkhorst Alwin D. R. Huitema Jos H. Beijnen Ren Bernards Jan H. M. Schellens 《Cancer chemotherapy and pharmacology》2020,85(5):917-930
KRAS oncogene mutations cause sustained signaling through the MAPK pathway. Concurrent inhibition of MEK, EGFR, and HER2 resulted in complete inhibition of tumor growth in KRAS-mutant (KRASm) and PIK3CA wild-type tumors, in vitro and in vivo. In this phase I study, patients with advanced KRASm and PIK3CA wild-type colorectal cancer (CRC), non-small cell lung cancer (NSCLC), and pancreatic cancer, were treated with combined lapatinib and trametinib to assess the recommended phase 2 regimen (RP2R). Patients received escalating doses of continuous or intermittent once daily (QD) orally administered lapatinib and trametinib, starting at 750 mg and 1 mg continuously, respectively. Thirty-four patients (16 CRC, 15 NSCLC, three pancreatic cancers) were enrolled across six dose levels and eight patients experienced dose-limiting toxicities, including grade 3 diarrhea (n = 2), rash (n = 2), nausea (n = 1), multiple grade 2 toxicities (n = 1), and aspartate aminotransferase elevation (n = 1), resulting in the inability to receive 75% of planned doses (n = 2) or treatment delay (n = 2). The RP2R with continuous dosing was 750 mg lapatinib QD plus 1 mg trametinib QD and with intermittent dosing 750 mg lapatinib QD and trametinib 1.5 mg QD 5 days on/2 days off. Regression of target lesions was seen in 6 of the 24 patients evaluable for response, with one confirmed partial response in NSCLC. Pharmacokinetic results were as expected. Lapatinib and trametinib could be combined in an intermittent dosing schedule in patients with manageable toxicity. Preliminary signs of anti-tumor activity in NSCLC have been observed and pharmacodynamic target engagement was demonstrated. 相似文献
2.
Arthur I. Kooyker Esther Toes-Zoutendijk Annemieke W.J. Opstal-van Winden Manon C.W. Spaander Maaike Buskermolen Hanneke J. van Vuuren Ernst J. Kuipers Folkert J. van Kemenade Chris Ramakers Maarten G.J. Thomeer Evelien Dekker Iris D. Nagtegaal Harry J. de Koning Monique E. van Leerdam Iris Lansdorp-Vogelaar 《International journal of cancer. Journal international du cancer》2020,147(4):1098-1106
The Dutch colorectal cancer (CRC) screening program started in 2014, inviting the target population biennially to perform a fecal immunochemical test (FIT). We obtained prospectively collected data from the national screening information-system to present the results of the second round (2016) and evaluate the impact of increasing the FIT cut-off halfway through the first round from 15 to 47 μg Hb/g feces on outcomes in the second round. Second round screening was done with a 47 μg Hb/g feces FIT cut-off. Participants were classified based on first round participation status as either FIT (15,47) or FIT (47,47) participants, and previous nonparticipants. In total, 348,891 (75.9%) out of 459,740 invitees participated in the second round. Participation rates were 93.4% among previous participants and 21.0% among previous non-participants. FIT(47,47) participants had a significantly higher detection rate of AN (15.3 vs. 10.4 per 1,000 participants) compared to FIT(15,47) participants in the second round, while their cumulative detection rate of AN over two rounds was significantly lower (45.6 vs. 52.6 per 1,000 participants). Our results showed that participation in the Dutch CRC screening program was consistently high and that second round detection rates depended on the first round FIT cut-off. The cumulative detection over two rounds was higher among FIT(15,47) participants. These findings suggest that a substantial part of, but not all the missed findings in the first round due to the increased FIT cut-off were detected in the subsequent round. 相似文献
3.
Sanne J. H. van Rooij Ryan D. Smith Anaïs F. Stenson Timothy D. Ely Xinyi Yang Nim Tottenham Jennifer S. Stevens Tanja Jovanovic 《Depression and anxiety》2020,37(4):303-312
Most studies investigating the effect of childhood trauma on the brain are retrospective and mainly focus on maltreatment, whereas different types of trauma exposure such as growing up in a violent neighborhood, as well as developmental stage, could have differential effects on brain structure and function. The current magnetic resonance imaging study assessed the effect of trauma exposure broadly and violence exposure more specifically, as well as developmental stage on the fear neurocircuitry in 8‐ to 14‐year‐old children and adolescents (N = 69). We observed reduced hippocampal and increased amygdala volume with increasing levels of trauma exposure. Second, higher levels of violence exposure were associated with increased activation in the amygdala, hippocampus, and ventromedial prefrontal cortex during emotional response inhibition. This association was specifically observed in children younger than 10 years. Finally, increased functional connectivity between the amygdala and brainstem was associated with higher levels of violence exposure. Based on the current findings, it could be hypothesized that trauma exposure during childhood results in structural changes that are associated with later risk for psychiatric disorders. At the same time, it could be postulated that growing up in an unsafe environment leads the brain to functionally adapt to this situation in a way that promotes survival, where the long‐term costs or consequences of these adaptations are largely unknown and an area for future investigations. 相似文献
4.
Straetmans Jos M. J. A. A. Stuut Marijn Wagemakers Sanne Hoebers Frank Kaanders Johannes H. A. M. Speel Ernst Jan M. Melchers Willem J. G. Slootweg Piet Kremer Bernd Lacko Martin Takes Robert P. 《European archives of oto-rhino-laryngology》2020,277(6):1753-1761
European Archives of Oto-Rhino-Laryngology - Debate on the extent of treatment of neck metastasis of cancer of unknown primary tumors (CUPs) is still ongoing. In two Dutch tertiary referral... 相似文献
5.
Sexuality and Disability - The influence of a spinal cord injury on sexuality must be seen in the light of sexuality being a central aspect of being human according to WHO. The term is broad and... 相似文献
6.
Sanne C. Lith Bram W. van Os Tom T.P. Seijkens Carlie J.M. de Vries 《European journal of immunology》2020,50(11):1643-1652
The nuclear receptor Nur77 is expressed in a multitude of tissues, regulating cell differentiation and homeostasis. Dysregulation of Nur77 signaling is associated with cancer, cardiovascular disease, and disorders of the CNS. The role of Nur77 in T cells has been studied for almost 30 years now. There is a clear appreciation that Nur77 is crucial for apoptosis of self-reactive T cells. However, the regulation and function of Nur77 in mature T cells remains largely unclear. In an exciting development, Nur77 has been recently demonstrated to impinge on cancer immunotherapy involving chimeric antigen receptor (CAR) T cells and tumor infiltrating lymphocytes (TILs). These studies indicated that Nur77 deficiency reduced T cell tolerance and exhaustion, thus raising the effectiveness of immune therapy in mice. Based on these novel insights, it may be proposed that regulation of Nur77 activity holds promise for innovative drug development in the field of cellular immunotherapy in cancer. In this review, we therefore summarize the role of Nur77 in T cell selection and maturation; and further develop the idea of targeting its activity in these cells as a potential strategy to augment current cancer immunotherapy treatments. 相似文献
7.
Emilie M.J. van Brummelen Sanne Huijberts Carla van Herpen Ingrid Desar Frans Opdam Robin van Geel Serena Marchetti Neeltje Steeghs Kim Monkhorst Bas Thijssen Hilde Rosing Alwin Huitema Jos Beijnen Rene Bernards Jan Schellens 《The oncologist》2021,26(4):290-e545
Lessons Learned
- Afatinib and selumetinib can be combined in continuous and intermittent dosing schedules, albeit at lower doses than approved for monotherapy.
- Maximum tolerated dose for continuous and intermittent schedules is afatinib 20 mg once daily and selumetinib 25 mg b.i.d.
- Because the anticancer activity was limited, further development of this combination is not recommended until better biomarkers for response and resistance are defined.
8.
Judith E. Grolleman Richarda M. de Voer Fadwa A. Elsayed Maartje Nielsen Robbert D.A. Weren Claire Palles Marjolijn J.L. Ligtenberg Janet R. Vos Sanne W. ten Broeke Noel F.C.C. de Miranda Renske A. Kuiper Eveline J. Kamping Erik A.M. Jansen M. Elisa Vink-Börger Isabell Popp Alois Lang Isabel Spier Robert Hüneburg Roland P. Kuiper 《Cancer cell》2019,35(2):256-266.e5
9.
10.
Life expectancy with and without dementia in persons with mild cognitive impairment in the community